An exploratory study of the usage in the human body based on wrist pulse detector using digital speckle pattern interferometry

注册号:

Registration number:

ITMCTR2023000022

最近更新日期:

Date of Last Refreshed on:

2023-07-24

注册时间:

Date of Registration:

2023-07-24

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

基于数字散斑干涉腕脉搏探测仪的人体应用的探索性研究

Public title:

An exploratory study of the usage in the human body based on wrist pulse detector using digital speckle pattern interferometry

注册题目简写:

English Acronym:

研究课题的正式科学名称:

数字散斑干涉腕脉搏光学精密传感理论与信息解耦方法

Scientific title:

Precision detection of wrist pulse using digital speckle pattern interferometry

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

訾明杰

研究负责人:

吴思进

Applicant:

ZI Mingjie

Study leader:

WU Sijin

申请注册联系人电话:

Applicant telephone:

13621052996

研究负责人电话:

Study leader's telephone:

13522933207

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

drzimingjie@126.com

研究负责人电子邮件:

Study leader's E-mail:

swu@bistu.edu.cn

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

北京市海淀区西苑操场1号院中国中医科学院西苑医院

研究负责人通讯地址:

北京市海淀区清河小营东路12号

Applicant address:

Xiyuan Hospital, China Academy of Chinese Medical Sciences, No.1 Xiyuan Playground, Haidian District, Beijing

Study leader's address:

12 Xiaoying East Road, Qinghe, Haidian District, Beijing

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

中国中医科学院西苑医院

Applicant's institution:

Xiyuan Hospital, China Academy of Chinese Medical Sciences

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

中国中医科学院西苑医院医学伦理委员会2023XLA088

伦理委员会批件附件:

Approved file of Ethical Committee:

View

批准本研究的伦理委员会名称:

中国中医科学院西苑医院医学伦理委员会

Name of the ethic committee:

Clinical Research Ethics Committee of Xiyuan Hospital of China Academy of Chinese Medical Science

伦理委员会批准日期:

Date of approved by ethic committee:

2023/7/21 0:00:00

伦理委员会联系人:

訾明杰

Contact Name of the ethic committee:

ZI Mingjie

伦理委员会联系地址:

北京市海淀区西苑操场1号院中国中医科学院西苑医院

Contact Address of the ethic committee:

Xiyuan Hospital, China Academy of Chinese Medical Sciences, No.1 Xiyuan Playground, Haidian District, Beijing

伦理委员会联系人电话:

Contact phone of the ethic committee:

010-62835646

伦理委员会联系人邮箱:

Contact email of the ethic committee:

drzimingjie@126.com

研究实施负责(组长)单位:

中国中医科学院西苑医院

Primary sponsor:

Xiyuan Hospital, China Academy of Chinese Medical Sciences

研究实施负责(组长)单位地址:

北京市海淀区西苑操场1号院中国中医科学院西苑医院

Primary sponsor's address:

Xiyuan Hospital, China Academy of Chinese Medical Sciences, No.1 Xiyuan Playground, Haidian District, Beijing

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

北京市

市(区县):

Country:

China

Province:

Beijing

City:

单位(医院):

中国中医科学院西苑医院

具体地址:

北京市海淀区西苑操场1号院中国中医科学院西苑医院

Institution
hospital:

Xiyuan Hospital, China Academy of Chinese Medical Sciences

Address:

Xiyuan Hospital, China Academy of Chinese Medical Sciences, No.1 Xiyuan Playground, Haidian District, Beijing

经费或物资来源:

北京市自然科学基金

Source(s) of funding:

Beijing Natural Science Foundation

研究疾病:

研究疾病代码:

Target disease:

no

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

横断面

Cross-sectional

研究所处阶段:

Study phase:

探索性研究/预试验

Pilot clinical trial

研究目的:

(1)评价DSPI脉搏及其特定皮肤检测的稳定性与重现性。 (2)通过中医临床不同刺激结果与DSPI对应性研究,评价该设备在不同皮肤条件下、不同时间点的一致性、稳定性和重现性。

Objectives of Study:

(1) Evaluation of DSPI for Pulse Detection and Stability/Reproducibility on Specific Skin. (2) By employing different stimulations, comparing the DSPI detection results with traditional Chinese pulse diagnosis, evaluating the device's consistency, stability, and reproducibility under various skin conditions and at different time points.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

(1)年龄20-30岁,男女不限。 (2)健康受试者的定义为在病史、生命体征、体格检查等方面均正常或轻度异常但无临床意义、或研究者判断认为合格者。 (3)受试者自愿签署书面的知情同意书;

Inclusion criteria

(1) Age range of 20-30 years, both males and females are eligible. (2) Healthy subjects are defined as individuals with normal or mildly abnormal medical history, vital signs, physical examination, etc., without clinical significance, or those deemed qualified by the researcher's judgment. (3) Subjects voluntarily sign a written informed consent form

排除标准:

(1)被测者双侧腕部寸口脉诊部位有破溃、疤痕等损伤或有穿刺史者。 (2)女性在测试当日适逢月经期。

Exclusion criteria:

(1) Exclusion criteria include subjects with injuries such as open wounds, scars, or a history of puncture at the radial artery pulse measurement sites on both wrists. (2) Female participants who are menstruating on the day of the test are excluded.

研究实施时间:

Study execute time:

From 2023-07-24

To      2023-12-31

征募观察对象时间:

Recruiting time:

From 2023-07-24

To      2023-12-31

干预措施:

Interventions:

组别:

艾灸组

样本量:

4

Group:

Moxibustion group

Sample size:

干预措施:

艾灸

干预措施代码:

Intervention:

Moxibustion

Intervention code:

组别:

高温组

样本量:

4

Group:

High temperature group

Sample size:

干预措施:

体温维持仪

干预措施代码:

Intervention:

Body temperature maintenance apparatus

Intervention code:

组别:

低温组

样本量:

4

Group:

Low temperature group

Sample size:

干预措施:

制冷风扇

干预措施代码:

Intervention:

Cooling fan

Intervention code:

组别:

针刺组

样本量:

4

Group:

Acupuncture group

Sample size:

干预措施:

针刺

干预措施代码:

Intervention:

Acupuncture

Intervention code:

组别:

干燥组

样本量:

4

Group:

dry group

Sample size:

干预措施:

吹风机

干预措施代码:

Intervention:

hair dryer

Intervention code:

组别:

潮湿组

样本量:

4

Group:

Wet group

Sample size:

干预措施:

水及甘油

干预措施代码:

Intervention:

Water and glycerin

Intervention code:

样本总量 Total sample size : 4

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

北京市

市(区县):

Country:

China

Province:

Beijing

City:

单位(医院):

中国中医科学院西苑医院

单位级别:

北京市海淀区西苑操场1号院中国中医科学院西苑医院

Institution/hospital:

Xiyuan Hospital, China Academy of Chinese Medical Sciences

Level of the institution:

Xiyuan Hospital, China Academy of Chinese Medical Sciences, No.1 Xiyuan Playground, Haidian District, Beijing

测量指标:

Outcomes:

指标中文名:

DSPI检测数据

指标类型:

主要指标

Outcome:

DSPI detection data

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

腹部及心脏超声

指标类型:

次要指标

Outcome:

Abdominal and cardiac ultrasound

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

尿常规

指标类型:

次要指标

Outcome:

Urine routine test

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

生化检测

指标类型:

次要指标

Outcome:

Biochemical tests

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血常规

指标类型:

次要指标

Outcome:

Blood routine test

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血样

组织:

Sample Name:

blood

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

征募研究对象情况:

尚未开始

Not yet recruiting

年龄范围:

最小 20
Min age years
最大 30
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

不使用随机方法

Randomization Procedure (please state who generates the random number sequence and by what method):

No random method was used

盲法:

Blinding:

是否共享原始数据:

IPD sharing:

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

中国临床试验注册中心

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Chinese Clinical Trail Registry

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

检测数据的处理和录入由专业人员完成,并进行多次的比对,确保数据的准确性。所有研究资料中不能注明受试者的姓名及其能识别身份的隐私信息。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

The processing and entry of the test data will be conducted by professional personnel, with multiple cross-references to ensure data accuracy. All research materials will not include the names of the subjects or any personally identifiable information to safeguard their privacy.

数据管理委员会:

Data Managemen Committee:

Yes

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

ITMCTR BJ-ICP:07032215-5 Tip: IE8 is recommended Use the system with widescreen display resolution above